In this study, we demonstrated that empagliflozin showed a beneficial effect towards decreasing urinary and circulating cell-free mtDNA copy numbers and urinary IL-1β in patients with T2DM. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.